A recent partnership between BrainChip Holdings and NaNose Medical has yielded a new COVID-19 testing solution boasting higher accuracy than RT-PCR screening. The Nano Artificial Nose is said to actively analyze patient breath samples while remaining highly portable. How exactly does it work? Officially dubbed the DiaNose, NaNose's technology has actually existed since 2017. Based on the Technion Israeli Institute of Technology's artificial nose, the device has since screened numerous patients for Parkinson's disease, cancer, kidney failure, and MS.
Mar-9-2021, 00:20:33 GMT